Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the American College of Cardiology

• Publication date

  2010-03-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2009.11.056PMID 20298932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis

  2009cited by this paper
• Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.

  2008cited by this paper
• Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging.

  2007cited by this paper
• Pathology of the vulnerable plaque.

  2007cited by this paper
• Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: cytokine profiling implications.

  2007cited by this paper
• Tetracyclines: nonantibiotic properties and their clinical implications.

  2006cited by this paper
• Minocycline for the treatment of Takayasu arteritis.

  2005cited by this paper
• Azithromycin for the secondary prevention of coronary events.

  2005cited by this paper
• Noninvasive Targeted Imaging of Matrix Metalloproteinase Activation in a Murine Model of Postinfarction Remodeling

  2005cited by this paper
• The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism

  2004cited by this paper
• Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial

  2004cited by this paper
• Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO.

  2004cited by this paper
• Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V: A Technique With Potential for Noninvasive Imaging of Vulnerable Plaque

  2003cited by this paper
• A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Minocycline Inhibits Smooth Muscle Cell Proliferation, Migration and Neointima Formation after Arterial Injury

  2003cited by this paper
• Prospective, Randomized, Double-Blind Trial Investigating the Effect of Doxycycline on Matrix Metalloproteinase Expression Within Atherosclerotic Carotid Plaques

  2002cited by this paper
• Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice.

  2002cited by this paper
• Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury.

  2002cited by this paper
• Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

  2002cited by this paper
• A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury.

  2001cited by this paper
• An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro

  2001cited by this paper
• A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury.

  2001cited by this paper
• Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery.

  2000cited by this paper
• Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.

  2000cited by this paper
• Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study

  2000cited by this paper
• Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

  2000cited by this paper
• Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

  2000cited by this paper
• Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

  2000cited by this paper
• Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis.

  2000cited by this paper
• Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.

  1999cited by this paper
• Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis

  1998cited by this paper
• Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1-treated articular cartilage.

  1998cited by this paper
• In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation.

  1998cited by this paper
• Differences in cardiovascular disease risk factors in black and white young adults: comparisons among five communities of the CARDIA and the Bogalusa heart studies. Coronary Artery Risk Development In Young Adults.

  1998cited by this paper
• Inhibition of MMP Synthesis by Doxycycline and Chemically Modified Tetracyclines (CMTs) in Human Endothelial Cells

  1998cited by this paper
• Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease.

  1998cited by this paper
• Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms

  1998cited by this paper
• Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.

  1998cited by this paper
• Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.

  1996cited by this paper
• Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity.

  1996cited by this paper
• Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells.

  1995cited by this paper
• Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

  1995cited by this paper
• Doxycycline and Chemically Modified Tetracyclines Inhibit Gelatinase A (MMP‐2) Gene Expression in Human Skin Keratinocytes

  1994cited by this paper
• Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.

  1992cited by this paper
• Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.

  1991cited by this paper
• Tetracyclines inhibit human synovial collagenase in vivo and in vitro.

  1987cited by this paper
• This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba

  year unknowncited by this paper

• Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)

  2025cites this paper
• Uncovering atherosclerotic cardiovascular disease by PET imaging

  2024cites this paper
• The roles of MMP8/MMP10 polymorphisms in ischemic stroke susceptibility

  2022cites this paper
• Dual-responsive Targeted Atherosclerosis Therapy through a Multi-effective Nanoplatform with Anti-inflammatory, Lipid-regulating and Autophagy

  2022cites this paper
• MMP9 SNP and MMP SNP–SNP interactions increase the risk for ischemic stroke in the Han Hakka population

  2021cites this paper
• Neural Stem Cells for Early Ischemic Stroke

  2021cites this paper
• Age-associated arterial calcification: the current pursuit of aggravating and mitigating factors

  2020cites this paper
• Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries

  2020cites this paper
• Playing slot to hitting the jackpot in molecular imaging: On probability of uncovering subcellular pathogenesis vs achieving clinical applicability

  2018cites this paper
• Neural stem cell therapy for subacute and chronic ischemic stroke

  2018cites this paper
• Immunomodulatory tetracyclines: Facing the complexity of intestinal inflammation

  2017cites this paper
• Cell‐based and pharmacological neurorestorative therapies for ischemic stroke

  2017cites this paper
• 18F-Fluoride Imaging and Other Plaque-Seeking Diagnostic Strategies: Understanding the Reality and Setting the Ground Rules….

  2017cites this paper
• Combination of rosuvastatin and probucol inhibits MMP-9 expression via upregulation of miR-497 in cultured HUVECs and apoE knockout mice

  2016cites this paper
• Optical imaging of MMP-12 active form in inflammation and aneurysm

  2016cites this paper
• Development and preclinical comparison of two non- peptidomimetic MMP/ADAM inhibitors for PET

  2015cites this paper
• Design, (radio)synthesis and applications of radiolabelled matrix metalloproteinase inhibitors for PET

  2015cites this paper
• Introduction of the JSNC Award—Scope and Recent Research Topics from JSNC Award Memorial Lectures—

  2015cites this paper
• Jagat Narula, MD, PhD: A conversation with the editor.

  2014cites this paper
• Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

  2014cites this paper
• Molecular Imaging of the Cardiac Extracellular Matrix

  2014cites this paper
• Lipid lowering and imaging protease activation in atherosclerosis

  2014cites this paper
• Influence of polyphenol extract from evening primrose (Oenothera paradoxa) seeds on human prostate and breast cancer cell lines.

  2014cites this paper
• Noninvasive MRI Monitoring of the Effect of Interventions on Endothelial Permeability in Murine Atherosclerosis Using an Albumin‐Binding Contrast Agent

  2013influential citation
• Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production.

  2013cites this paper
• Effect of minocycline on carotid atherosclerotic plaques

  2013cites this paper
• 18F-FDG Imaging of Carotid Arteries for Identifying the Vulnerable Patient: Are We at the Beginning of the End?

  2013cites this paper
• Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.

  2013cites this paper
• University of Groningen Probes for Non-invasive Matrix Metalloproteinase-targeted Imaging with PET and SPECT Matusiak,

  2013cites this paper
• Molecular Imaging of Vascular Inflammation, Atherosclerosis, and Thrombosis

  2012cites this paper
• Minocycline in infammatory bowel disease: far beyond an antibiotic

  2012cites this paper
• Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits

  2012cites this paper
• Tetracyclines: drugs with huge therapeutic potential.

  2012cites this paper
• Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.

  2012cites this paper
• Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.

  2012cites this paper
• In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.

  2012cites this paper
• Gadofosveset monitors the effects of different interventions on endothelial permeability and plaque progression

  2011cites this paper
• Matrix Metalloproteinase-9 is a Diagnostic Marker of Heterotopic Ossification in a Murine Model

  2011cites this paper
• Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1).

  2011cites this paper
• Matrix Metalloproteinase Activation Predicts Amelioration of Remodeling After Dietary Modification in Injured Arteries

  2011cites this paper
• Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo

  2011cites this paper
• Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by In Vivo Molecular Imaging of Matrix Metalloproteinase Activation

  2011cites this paper
• Hyperbaric Oxygen Effect on MMP-9 After a Vascular Insult

  2010cites this paper